SAbR For Oligometastatic Renal Cell Carcinoma
NCT02956798
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Oligometastatic Renal Cell Carcinoma
Interventions
RADIATION:
Stereotactic ablative body radiation (SABR)
Sponsor
University of Texas Southwestern Medical Center